ConceptioArchiveClinicalTrials.gov
ClinicalTrials.govpublic full text

Alemtuzumab (Campath-1H) Monoclonal Antibody in Patients With Relapsed and Resistant Classical Hodgkin's Disease

M.D. Anderson Cancer Center · 2005
ClinicalTrials.gov · Datasets · License: Public Domain · 2005
Open Source ↗
1hlymphoma
hodgkin's disease, lymphoma, campath-1h monoclonal antibody, alemtuzumab, campath, campath-1h, relapsed and resistant classical hodgkin's disease, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 900497
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.